SRTSSensus Healthcare, Inc.

Nasdaq sensushealthcare.com


$ 3.84 $ 0.05 (1.32 %)    

Wednesday, 08-May-2024 15:49:17 EDT
QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 3.83
$ 3.83
$ 0.00 x 0
$ 0.00 x 0
$ 3.73 - $ 3.92
$ 1.79 - $ 5.38
158,071
na
62.3M
$ 1.11
$ 140.63
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-15-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-11-2023 06-30-2023 10-Q
4 05-12-2023 03-31-2023 10-Q
5 03-23-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-12-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-25-2022 12-31-2021 10-K
10 11-10-2021 09-30-2021 10-Q
11 08-13-2021 06-30-2021 10-Q
12 05-14-2021 03-31-2021 10-Q
13 03-05-2021 12-31-2020 10-K
14 11-10-2020 09-30-2020 10-Q
15 08-10-2020 06-30-2020 10-Q
16 05-11-2020 03-31-2020 10-Q
17 03-06-2020 12-31-2019 10-K
18 11-08-2019 09-30-2019 10-Q
19 08-12-2019 06-30-2019 10-Q
20 05-14-2019 03-31-2019 10-Q
21 03-15-2019 12-31-2018 10-K
22 11-06-2018 09-30-2018 10-Q
23 08-14-2018 06-30-2018 10-Q
24 05-08-2018 03-31-2018 10-Q
25 02-15-2018 12-31-2017 10-K
26 11-06-2017 09-30-2017 10-Q
27 08-04-2017 06-30-2017 10-Q
28 05-09-2017 03-31-2017 10-Q
29 03-10-2017 12-31-2016 10-K
30 11-07-2016 09-30-2016 10-Q
31 08-15-2016 06-30-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 sensus-healthcare-announces-sale-of-first-srt-100-vision-system-to-asia-no-financial-terms-disclosed

Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive treatments for b...

 sensus-healthcare-q4-2023-gaap-eps-026-beats-012-estimate-sales-1257m-beat-1106m-estimate

Sensus Healthcare (NASDAQ:SRTS) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0....

 earnings-scheduled-for-february-8-2024

Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share ...

 sensus-healthcare-collaborates-with-curerays-curerays-to-provide-sensus-dermatology-customers-oversight-and-supervision-will-research-new-indications-for-sensus-superficial-radiotherapy

Physician-run radiation oncology innovator also to research new indications and broaden the market for SRT to include inflammat...

 why-3m-shares-are-trading-lower-by-over-12-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of 3M Company (NYSE: MMM) fell sharply during Tuesday’s session after the company reported better-than-expected fourth-q...

 sensus-healthcare-announces-preliminary-q4-revenue-of-12m-and-2023-revenue-exceeding-23m

Ships more than 60 SRT units in 2023To report full financial results and hold conference call on February 8thBOCA RATON, Fla. ,...

 hc-wainwright--co-reiterates-buy-on-sensus-healthcare-maintains-8-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Sensus Healthcare (NASDAQ:SRTS) with a Buy and maintains $8 price target.

 sensus-healthcare-q3-2023-eps-009-misses-002-estimate-sales-390m-miss-588m-estimate

Sensus Healthcare (NASDAQ:SRTS) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $...

 earnings-scheduled-for-november-9-2023

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on re...

 sensus-healthcare-to-showcase-its-full-line-of-cutting-edge-superficial-radiotherapy-devices-for-the-treatment-of-non-melanoma-skin-cancer-at-astro-2023-in-san-diego

Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invas...

 sensus-healthcare-announces-new-3m-share-repurchase-program

 Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-inva...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION